Institute For Ethnomedicine Inc
- Assets
- $4.6m
- Revenue
- $3.2m
- Investments
- $0.0
- Employees
- 5
- Location
- Provo, UT
- Founding
- 04/2005
- Data as of
- 12/2021
- EIN
- 20-1829529
Organization Overview
Institute For Ethnomedicine Inc is located in Provo, UT. The organization was established in 2005. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2021, Institute For Ethnomedicine Inc employed 5 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Ethnomedicine Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Institute For Ethnomedicine Inc generated $3.2m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 10.6% each year . All expenses for the organization totaled $3.2m during the year ending 12/2021. While expenses have increased by 5.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE INSTITUTE FOR ETHNOMEDICINE SEARCHES FOR NEW CURES BY STUDYING PLANT MEDICINE AND PATTERNS OF WELLNESS AND DISEASE AMONG INDIGENOUS PEOPLE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
RESEARCH BY THE INSTITUTE AND MEMBERS OF OUR GLOBAL SCIENTIFIC CONSORTIUM IDENTIFIED THE AMINO ACID L-SERINE AS A POTENTIAL DRUG CANDIDATE. THE INSTITUTE HAS STUDIED THE POTENTIAL OF L-SERINE AS A NOVEL THERAPY FOR THE TREATMENT OF ALS AND OTHER NEURODEGENERATIVE ILLNESSES THROUGH IN VITRO AND IN VIVO EXPERIMENTS, AS WELL AS FDA-APPROVED HUMAN CLINICAL TRIALS. THESE EXPERIMENTS SUGGEST THAT WHILE L-SERINE AT THE DOSES STUDIED CANNOT STOP OR REVERSE NEURODEGENERATION ASSOCIATED WITH ALS, THAT L-SERINE MAY SLOW DISEASE PROGRESSION.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Paul Alan Cox PHD Executive Dir. | Officer | 40 | $295,300 |
Sandra Banack Senior Scientist | 40 | $180,800 | |
William C Egan III Chairman | Trustee | 0 | $0 |
Gordon Deane Director | Trustee | 0 | $0 |
Joseph Merrill Director | Trustee | 0 | $0 |
Douglas M Kinney Director | Trustee | 0 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,085,775 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $3,085,775 |
| Total Program Service Revenue | $0 |
| Investment income | $1,467 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $88,033 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $3,175,275 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $295,300 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $554,581 |
| Pension plan accruals and contributions | $84,200 |
| Other employee benefits | $160,908 |
| Payroll taxes | $52,267 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $353,020 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $81,694 |
| Travel | $13,939 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $258,983 |
| Insurance | $0 |
| All other expenses | $55,947 |
| Total functional expenses | $3,235,323 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $2,900,447 |
| Pledges and grants receivable | $700,800 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $19,200 |
| Net Land, buildings, and equipment | $951,436 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $22,300 |
| Total assets | $4,594,183 |
| Accounts payable and accrued expenses | $24,356 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $24,356 |
| Net assets without donor restrictions | $4,569,827 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,594,183 |
Grants Recieved
Over the last fiscal year, we have identified 9 grants that Institute For Ethnomedicine Inc has recieved totaling $190,447.
| Awarding Organization | Amount |
|---|---|
Community Foundation Of Jackson Hole Jackson, WY PURPOSE: GENERAL OPERATING SUPPORT | $104,542 |
Dallas Foundation A Tx Nonprofit Corporation Dallas, TX PURPOSE: GENERAL SUPPORT | $35,000 |
Memory For Memory Inc West Palm Beach, FL PURPOSE: General Fund | $20,000 |
Morgan Stanley Global Impact Funding Trust Inc Indianapolis, IN PURPOSE: UNRESTRICTED GENERAL SUPPORT | $10,000 |
Melville Foundation North Palm Beach, FL PURPOSE: CHARITABLE GRANT | $10,000 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $6,850 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Research Corporation Tucson, AZ | $242,008,144 | $26,138,153 |
Southwest Autism Research And Resource Center Phoenix, AZ | $18,925,029 | $16,667,407 |
Biomedical Research Institute Of New Mexico Albuquerque, NM | $13,199,153 | $8,153,350 |
Glenn Foundation For Medical Research Inc Phoenix, AZ | $192,520,690 | $23,653,368 |
Cholangiocarcinoma Foundation Salt Lake City, UT | $4,018,118 | $4,935,665 |
Colorado Wheat Research Foundation Inc Fort Collins, CO | $552,396 | $3,293,864 |
National Community Health Partners Sahuarita, AZ | $263,343 | $3,493,424 |
Institute For Ethnomedicine Inc Provo, UT | $4,594,183 | $3,175,275 |
Realm Of Caring Foundation Inc Colorado Springs, CO | $636,138 | $1,085,312 |
Community Rebuilds Moab, UT | $3,526,595 | $1,041,551 |
Arizona Elks Major Projects Inc Tucson, AZ | $7,581,052 | $955,588 |
Interventional Orthopedics Foundation Denver, CO | $902,096 | $364,758 |